{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:29:33Z","timestamp":1778585373501,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bbr.2016.03.024","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T17:49:36Z","timestamp":1458064176000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Brain site- and transmitter-dependent actions of methamphetamine, morphine and antipsychotics"],"prefix":"10.1016","volume":"306","author":[{"given":"Tomohisa","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbr.2016.03.024_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000066236","article-title":"Disturbance of consciousness due to methamphetamine abuse. a study of 2 patients","volume":"31","author":"Nakatani","year":"1998","journal-title":"Psychopathology"},{"issue":"1","key":"10.1016\/j.bbr.2016.03.024_bib0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11481-011-9288-1","article-title":"Methamphetamine-associated psychosis","volume":"7","author":"Grant","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbr.2016.03.024_bib0015","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1186\/1757-1626-2-9391","article-title":"Morphine-induced hallucinations\u2014resolution with switching to oxycodone: a case report and review of the literature","volume":"2","author":"Chowdhury","year":"2009","journal-title":"Cases J."},{"key":"10.1016\/j.bbr.2016.03.024_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroscience.2011.08.023","article-title":"Dynamicre gulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms","volume":"198","author":"Morikawa","year":"2001","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bbr.2016.03.024_bib0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","article-title":"The mysterious motivational functions of mesolimbic dopamine","volume":"76","author":"Salamone","year":"2012","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.bbr.2016.03.024_bib0030","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","article-title":"Animal models of Parkinson\u2019s disease","volume":"279","author":"Blandini","year":"2012","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.bbr.2016.03.024_bib0035","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is there a common molecular pathway for addiction?","volume":"8","author":"Nester","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"S3","key":"10.1016\/j.bbr.2016.03.024_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-199803003-00009","article-title":"Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia","volume":"13","author":"Barnes","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2016.03.024_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/YCO.0b013e32832a16da","article-title":"Akathisia and second-generation antipsychotic drugs","volume":"21","author":"Kumar","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2016.03.024_bib0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-8993(92)91358-L","article-title":"Scopolamine attenuates haloperidol-induced c-fos expression in the striatum","volume":"588","author":"Guo","year":"1992","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.bbr.2016.03.024_bib0055","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.89.10.4270","article-title":"Differential expression of c-fos and zif268 in rat striatum after haloperidol: clozapine, amphetamine","volume":"89","author":"Nguyen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbr.2016.03.024_bib0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cercor\/6.4.561","article-title":"Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors","volume":"6","author":"Merchant","year":"1996","journal-title":"Cereb. Cortex"},{"issue":"4","key":"10.1016\/j.bbr.2016.03.024_bib0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1254\/jphs.FPJ04039X","article-title":"Combined effects of psychostimulants and morphine on locomotor activity in mice","volume":"96","author":"Mori","year":"2004","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2016.03.024_bib0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0091-3057(87)90485-0","article-title":"Effects of systemic and intracranial amphetamine injections on behavior in the open field: a detailed analysis","volume":"27","author":"Carr","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.bbr.2016.03.024_bib0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1523\/JNEUROSCI.10-01-00303.1990","article-title":"Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat","volume":"10","author":"Delfs","year":"1990","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2016.03.024_bib0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","article-title":"Occupancy of central neurotransmitter receptors by risperidone: clozapine and haloperidol, measured ex vivo by quantitative autoradiography","volume":"631","author":"Schotte","year":"1993","journal-title":"Brain Res."},{"issue":"S","key":"10.1016\/j.bbr.2016.03.024_bib0085","first-page":"5","article-title":"Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity","volume":"55","author":"Leysen","year":"1994","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbr.2016.03.024_bib0090","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0028-3908(93)90026-Y","article-title":"Blockade of morphine rewared through the activation of kappa-opioid receptors in mice","volume":"32","author":"Funada","year":"1993","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2016.03.024_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-4328(89)80005-1","article-title":"Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior","volume":"35","author":"Kelley","year":"1989","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2016.03.024_bib0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","article-title":"A neurobiological basis for substance abuse comorbidity in schizophrenia","volume":"50","author":"Chambers","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2016.03.024_bib0105","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1186\/1757-1626-2-9391","article-title":"Morphine-induced hallucinations\u2014resolution with switching to oxycodone: a case report and review of the literature","volume":"2","author":"Chowdhury","year":"2009","journal-title":"Cases J."},{"issue":"6","key":"10.1016\/j.bbr.2016.03.024_bib0110","first-page":"1019","article-title":"Management of common symptoms in terminally ill patients: part IIConstipation, delirium and dyspnea","volume":"64","author":"Ross","year":"2001","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbr.2016.03.024_bib0115","doi-asserted-by":"crossref","unstructured":"Mori T, Iwase Y, Saeki T, Iwata N, Murata A, Masukawa D, Suzuki T. Differential activation of dopaminergic systems in rat brain basal ganglia by morphine and methamphetamine. Neuroscience in press.","DOI":"10.1016\/j.neuroscience.2016.01.043"},{"issue":"1","key":"10.1016\/j.bbr.2016.03.024_bib0120","first-page":"121","article-title":"Perospirone (Sumitomo pharmaceuticals)","volume":"3","author":"De Paulis","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"18","key":"10.1016\/j.bbr.2016.03.024_bib0125","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0024-3205(90)90365-X","article-title":"The effect of serotonergic agents on haloperidol-induced catalepsy","volume":"47","author":"Hicks","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2016.03.024_bib0130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.npp.1300882","article-title":"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis","volume":"31","author":"Gouzoulis-Mayfrank","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.bbr.2016.03.024_bib0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mehy.2013.03.013","article-title":"A serotonin hypothesis of schizophrenia","volume":"80","author":"Eggers","year":"2013","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.bbr.2016.03.024_bib0140","first-page":"295","article-title":"The 5-HT hypothesis of schizophrenia","volume":"4","author":"Akhondzadeh","year":"2001","journal-title":"IDrugs"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816301498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816301498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T15:20:38Z","timestamp":1567696838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816301498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":28,"alternative-id":["S0166432816301498"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2016.03.024","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain site- and transmitter-dependent actions of methamphetamine, morphine and antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2016.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}